The UK Competition Authority investigates a pharmaceutical company for abuse of dominance (Essential Pharma)

L'Ecluse, Peter; Longeval, Catherine; T'Syen, Koen

Previous article The Turkish Administrative Court upholds the fines imposed by the Competition Authority on two electricity sales companies for abuse of dominance and annuls it for a third company (Rescs / Ayedas) Next article The UK Competition Authority opens an investigation into alleged abuse of dominance in the supply of drugs used to treat bipolar disorder (Essential Pharma)

6 Oct 2020

The UK Competition Authority investigates a pharmaceutical company for abuse of dominance (Essential Pharma)

KEYWORDS

Reference

UK Competition Authority, Essential Pharma, Press Release, 6 October 2020

On 6 October 2020, the Competition and Markets Authority ( CMA ) started an inquiry into Essential Pharma to determine whether that company abused an allegedly dominant position when announcing the withdrawal from the UK market of Priadel®,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Peter L’Ecluse
Van Bael & Bellis (Brussels)

Belgium 125 contributions 35263 visits
Catherine Longeval
Van Bael & Bellis (Brussels)

Belgium 34 contributions 12359 visits
Koen T’Syen
Van Bael & Bellis (Brussels)

Belgium 35 contributions 12466 visits

Quotation

Peter L'Ecluse, Catherine Longeval, Koen T'Syen, The UK Competition Authority investigates a pharmaceutical company for abuse of dominance (Essential Pharma), 6 October 2020, e-Competitions October 2020, Art. N° 97096

Visites 258